Pricing

Leap Therapeutics

1 follower

‌

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Douglas Onsi

President, CEO, CFO, Board Member

Douglas Onsi

Collapse

Cyndi Sirard

Chief Medical Officer

Gus Lawlor

Chief Operating Officer

Mark O'Mahony

Chief Manufacturing Officer

Walter Newman

Senior Research Fellow

Jason Baum

Chief Scientific Officer

Teams

Research and Scientific Team

7 members

Clinical Development Team

5 members

Manufacturing and Operations Team

5 members

Data Management and Analysis Team

3 members

Regulatory Affairs and Quality Team

3 members

Leadership Team

3 members

Similar companies

Immunome

2 followers

BeiGene

19 followers

Tessera Therapeutics

2 followers

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Thrive Capital

26 followers

aescape

6 followers

StorONE

6 followers

Render

5 followers

FlyQuest

1 follower

Explore companies